Sunitinib-induced pyoderma gangrenosum-like skin ulcer.
作者信息
Kuntz Thomas, Koushk-Jalali Bijan, Kreuter Alexander
机构信息
Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth, Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Nordrhein-Westfalen, Germany.
Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth, Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Nordrhein-Westfalen, Germany
出版信息
CMAJ. 2020 May 19;192(20):E552. doi: 10.1503/cmaj.191165.
Abstract
摘要
相似文献
1
Sunitinib-induced pyoderma gangrenosum-like skin ulcer.舒尼替尼诱发的坏疽性脓皮病样皮肤溃疡。
CMAJ. 2020 May 19;192(20):E552. doi: 10.1503/cmaj.191165.
2
Pyoderma Gangrenosum Associated with Sunitinib: A Case Report.伴发于舒尼替尼的坏疽性脓皮病：一例报告。
Adv Skin Wound Care. 2019 Sep;32(9):427-429. doi: 10.1097/01.ASW.0000577128.03996.95.
3
[Sunitinib-induced pyoderma gangrenosum].[舒尼替尼诱导的坏疽性脓皮病]
Ann Dermatol Venereol. 2013 Dec;140(12):841-2. doi: 10.1016/j.annder.2013.10.024. Epub 2013 Nov 8.
4
A case of pyoderma gangrenosum possibly associated with sunitinib treatment.1例可能与舒尼替尼治疗相关的坏疽性脓皮病。
Int J Dermatol. 2013 May;52(5):634-6. doi: 10.1111/j.1365-4632.2011.04952.x.
5
Pyoderma gangrenosum with the use of sunitinib.使用舒尼替尼治疗的坏疽性脓皮病。
J Clin Oncol. 2011 Apr 1;29(10):e266-7. doi: 10.1200/JCO.2010.32.6165. Epub 2011 Jan 10.
6
Sunitinib induced pyoderma gangrenosum-like ulcerations.舒尼替尼诱导的坏疽性脓皮病样溃疡。
Eur J Med Res. 2011 Nov 10;16(11):491-4. doi: 10.1186/2047-783x-16-11-491.
7
Pyoderma gangrenosum: another cutaneous side-effect of sunitinib?坏疽性脓皮病：舒尼替尼的另一种皮肤副作用？
Br J Dermatol. 2008 Jul;159(1):242-3. doi: 10.1111/j.1365-2133.2008.08599.x. Epub 2008 Jul 1.
8
Kidney cancer: Intermittent sunitinib is an effective renal carcinoma treatment.
Nat Rev Urol. 2017 May;14(5):264-266. doi: 10.1038/nrurol.2017.36. Epub 2017 Mar 7.
9
Nonthrombocytopenic, noninflammatory simplex purpura during sunitinib therapy.
Int J Dermatol. 2019 Aug;58(8):e153-e155. doi: 10.1111/ijd.14458. Epub 2019 Apr 8.
10
Sunitinib therapy as a cause of diffuse digestive tract hemorrhage in end-stage renal disease patient.
Saudi J Kidney Dis Transpl. 2018 Mar-Apr;29(2):483-484. doi: 10.4103/1319-2442.229278.
引用本文的文献
1
SPRR1B+ keratinocytes prime oral mucosa for rapid wound healing via STAT3 activation.SPRR1B+ 角质形成细胞通过激活 STAT3 为口腔黏膜的快速愈合做好准备。
Commun Biol. 2024 Sep 16;7(1):1155. doi: 10.1038/s42003-024-06864-5.
本文引用的文献
1
Pyoderma gangrenosum-like ulceration of the lower extremity secondary to sunitinib therapy: a case report.舒尼替尼治疗继发下肢坏疽性脓皮病样溃疡：1例报告
SAGE Open Med Case Rep. 2018 Jun 18;6:2050313X18783048. doi: 10.1177/2050313X18783048. eCollection 2018.
2
Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others.矛盾反应：抗肿瘤坏死因子α药物、乌司奴单抗、司库奇尤单抗、依奇珠单抗及其他药物。
Curr Probl Dermatol. 2018;53:49-63. doi: 10.1159/000479475. Epub 2017 Nov 7.
3
Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.接受多靶点激酶抑制剂索拉非尼和舒尼替尼治疗的患者的皮肤不良反应。
Br J Dermatol. 2009 Nov;161(5):1045-51. doi: 10.1111/j.1365-2133.2009.09290.x. Epub 2009 May 5.
Zotero 插件